Skip to content

Clinical trials

Phase 2 Lupus Erythematosus, Systemic trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Phase: Phase 2 Country / region: France Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20091
20102
20111
20121
20131
20141
20151
20161
20172
20182
20192
20202
20212
20222
20232
20242
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Terminated5
Active, not recruiting3
Not yet recruiting2
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris3
Novartis Pharmaceuticals3
Amgen2
Bristol-Myers Squibb2
Eli Lilly and Company2
AbbVie1
Alpine Immune Sciences Inc, A Subsidiary of Vertex1
Beeline Medicines Corporation1
Celgene1
Cephalon, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic30
Lupus Nephritis5
Autoimmune Diseases4
Arthritis, Rheumatoid3
Connective Tissue Diseases2
Immune System Diseases2
Aortic Arch Syndromes1
Behcet Syndrome1
Cholangitis, Sclerosing1
Colitis, Ulcerative1

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.